New Data Show Omicron Hospital Risk Significantly Lower Than Delta, FDA Approves Pfizer COVID Pill
Just before the FDA announced that it had officially approved Pfizer’s COVID pill for to patients age 12 and older (though the drug will likely only be used in more high-risk patients), new data arrived from both South Africa and Scotland showing the hospitalization risk from omicron is significantly lower than from delta.